First estradiol/norethisterone injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
News
First invitation of dexamethasone and remdesivir for Covid-19 published
M
The 1st Invitation to Manufacturers of therapeutics against COVID-19 to submit an Expression of Interest (EOI) for Product Evaluation was published today by the Prequalification Unit (PQT)
20th Invitation to Manufacturers of Antituberculosis Medicines to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit (PQT)
M
Changes to the 20th TB EOI
Nitrosamine concerns in Priftin (Rifapentine)
M
WHO Prequalification Unit - Medicines Assessment Team (PQ
Q&A: Dexamethasone and COVID-19
M
The World Health Organization (WHO) has welcomed the init
WHO Public Assessment Report (WHOPAR) for trastuzumab published
M
The below WHO Public Assessment Report (WHOPAR) for trastuzumab was published:
FAQ for variations updated
M
The WHO Prequalification Unit (PQT) updated the FAQ varia
First rituximab similar biotherapeutic products prequalified
M
On 25 May 2020 the World Health Organization (WHO) prequa
First rituximab similar biotherapeutic products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Ipca’s dispersible zinc tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zhejiang Jiangbei’s efavirenz tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ dolutegravir/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Request for Proposals: Support to Director, Regulation and Prequalification (RPQ) Department and to RPQ Unit Heads
ID
IVD
M
V
VCP
This is a request for proposals for consultancy services
Question & Answer - COVID-19 and WHO PQT Inspections
M
On 30 January 2020, WHO Director-General, Dr Tedros Ghebr
Laboratorios Leon Pharma’s levonorgestrel/ethinylestradiol tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Emcure’s emtricitabine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit – Medicines request to manufacturers to conduct risk assessments to evaluate the potential for the presence of nitrosamine impurities
M
Background
Medicine Regulatory Authorities firs
First meropenem prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Strides’ sofosbuvir 400 mg tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Emcure’s dolutegravir 50 mg tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Incepta’s medroxyprogesterone injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shanghai Harvest Pharmaceutical’s kanamycin injection prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Lupin’s emtricitabine/tenofovir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO publishes Emergency Use Listing procedure and roadmap to make new medical products more readily available during health emergencies
ID
IVD
M
V
VCP
WHO published the Emergency Use Listing (EUL) procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.